Literature DB >> 2848333

Pulmonary indoleamine 2,3-dioxygenase activity and its significance in the response of rats, mice, and rabbits to oxidative stress.

P T Daley-Yates1, A P Powell, L L Smith.   

Abstract

The physiological significance of the enzyme indoleamine 2,3,-dioxygenase (IDO) (EC 1.13.11.17), which consumes superoxide anion (O2-), is not known. Since this enzyme is found in high concentrations in lung tissue, we examined the possibility that IDO may protect against chemically induced oxidative stress in the lung. The induction of IDO by bacterial lipopolysaccharide (LPS) was found to be 20-fold in the mouse and 4-fold in the rat, but did not confer protection against paraquat-induced pulmonary toxicity. Moreover, paraquat, when dosed to rats or mice, did not induce pulmonary IDO activity. An elevation in the intracellular O2- concentration was sought by incubating lung slices with 5 mM diethyldithiocarbamate (DDTC) (to inhibit SOD), paraquat (10(-4) M), or methylene blue (10(-4) M) or under an atmosphere of 100% oxygen. These attempts did not enhance the IDO activity in lung slices prepared from control or LPS-treated rats and mice. There was also no evidence that the uptake of an IDO substrate, tryptophan, was limiting for IDO activity in rat and mouse lung slices. We have concluded in the case of rats and mice that the pulmonary IDO activity, even following induction, is too low for O2- to be the rate-limiting factor. For this reason IDO cannot act as a protective enzyme by scavenging O2- in the lung of these species. However, in the rabbit, a species comparatively resistant to paraquat- and oxygen-induced lung damage, pulmonary IDO activity is 170 times that of rats or mice. IDO activity in rabbit lung slices was increased 4-fold by incubation with 5 mM DDTC and 10-fold by incubation with methylene blue (10(-4) M). However, paraquat (10(-4) M and oxygen (100% atmosphere) were able to enhance IDO activity (5-fold) only when SOD had previously been inhibited. We have concluded that in the rabbit lung IDO is able to scavenge O2- and therefore has the potential to act as a protective enzyme in this species.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848333     DOI: 10.1016/0041-008x(88)90082-8

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

2.  Ferryl derivatives of human indoleamine 2,3-dioxygenase.

Authors:  Changyuan Lu; Syun-Ru Yeh
Journal:  J Biol Chem       Date:  2011-04-18       Impact factor: 5.157

3.  Aflatoxin B1 alters central and systemic tryptophan and tyrosine metabolism: influence of immunomodulatory drugs.

Authors:  L B Weekley
Journal:  Metab Brain Dis       Date:  1991-03       Impact factor: 3.584

4.  Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases.

Authors:  S Christen; E Peterhans; R Stocker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  Species and cell types difference in tryptophan metabolism.

Authors:  Yuki Murakami; Kuniaki Saito
Journal:  Int J Tryptophan Res       Date:  2013-07-21

6.  System in biology leading to cell pathology: stable protein-protein interactions after covalent modifications by small molecules or in transgenic cells.

Authors:  Halina Z Malina
Journal:  J Biomed Sci       Date:  2011-01-19       Impact factor: 8.410

7.  Decreased protein nitration in macrophages that overexpress indoleamine 2, 3-dioxygenase.

Authors:  Derin B Keskin; Brendan Marshall; David Munn; Andrew L Mellor; Debra A Gearhart
Journal:  Cell Mol Biol Lett       Date:  2006-11-13       Impact factor: 5.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.